Publication

Article

Internal Medicine World Report

May 2015
Volume

Painkillers During Pregnancy Might Reduce Testosterone Development

Author(s):

Extended use of paracetamol by pregnant women might impact male fetal testosterone development, according to research published in Science Translational Medicine.

Pregnant women using paracetamol for prolonged periods of time could reduce the production of their male babies’ testosterone, according to research on mice models published in Science Translational Medicine.

Researchers from the University of Edinburgh in Scotland examined animal models of acetaminophen doses during pregnancies in order to determine the effects of the drug on male offspring. The mice models, which had been castrated, carried grafts of human testicular tissue in order to continue the testosterone production. The grafts had previously demonstrated a similar ability to develop, grow, and function the way that human testes do during pregnancy.

The mice models were administered a typical daily dose of paracetamol over either a period of 24 hours or 7 days. The dose was given 3 times per day and was a human dose equivalent, measured based off of the 20 mg per kg of body weight recommendation. Then, the researchers measured the amount of testosterone produced by the human tissue 1 hour after the final dose of paracetamol.

There was no effect on the testosterone production from paracetamol treatment in the 24-hour dose group. In the 7 days treatment group, the amount of testosterone produced was reduced by 45%. Additionally, the weight of the seminal vesicle glands was reduced by 18 percent in the 7-day treatment group.

“Our results suggest that protracted use of acetaminophen (1 week) may suppress fetal testosterone production, which could have adverse consequences,” the authors concluded. “Further studies are required to establish the dose/ response and treatment/ duration relationships to delineate the maximum dose and treatment period without this adverse effect.”

The researchers wrote that lower testosterone exposure in fetal life is responsible for a majority of male reproductive disorders. However, they said that previously, the mechanisms that suppress fetal testosterone had been largely unknown.

“This study adds to existing evidence that prolonged use of paracetamol in pregnancy may increase the risk of reproductive disorders in male babies,” Rod Mitchell, a Wellcome Trust Intermediate Clinical Research Fellow at the University of Edinburgh, explained in a press release. “We would advise that pregnant women should follow current guidance that the painkiller be taken at the lowest effective dose for the shortest possible time.”

The researchers also commented that it is probably too early to tell if these results are applicable to human use of the painkiller. However, the results do caution against extended use of acetaminophen during pregnancy, they said.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.